Novo Nordisk's Chief Scientific Officer: The company expects to have at least five oral drug candidates in clinical development by the end of this year.
2026-09-21
Novo Nordisk's Chief Scientific Officer: The company expects to have at least five oral drug candidates in clinical development by the end of this year.